AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 210,000 shares at $100.95 ($23.1M) on 2026-05-20, disclosed to the SEC on 2026-05-22.
Open-market sale of $23.1M GH by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.95 | 200 | $20K | 0.1% |
| 2 | $102.57 | 900 | $92K | 0.4% |
| 3 | $103.82 | 1,366 | $142K | 0.6% |
| 4 | $105.01 | 11,919 | $1.3M | 5.4% |
| 5 | $105.88 | 1,200 | $127K | 0.6% |
| 6 | $106.99 | 21,171 |
| $2.3M |
| 9.8% |
| 7 | $108.11 | 33,069 | $3.6M | 15.5% |
| 8 | $108.97 | 9,852 | $1.1M | 4.7% |
| 9 | $110.10 | 28,908 | $3.2M | 13.8% |
| 10 | $111.14 | 37,163 | $4.1M | 17.9% |
| 11 | $112.02 | 37,900 | $4.2M | 18.4% |
| 12 | $112.76 | 26,352 | $3.0M | 12.9% |
| Total | $109.89 avg | 210,000 | $23.1M | 100% |
| Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |
| GH | SELL | 2025-07-02 | $10.2M | — | Filing → |